Rina Chin

5PUBLICATIONS
10CO-AUTHORS
PharmacogenomicsFood properties (incl. characteristics and health benefits)Epidemiology not elsewhere classifiedDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 21, 2026
Correction: Investigation of Severe Hypoglycemia Risk Among Patients with Diabetes Treated with Ultra-Rapid Lispro in Japan.

Seiko Mizuno, Machiko Minatoya, Satoshi Osaga

|Jul 25, 2025
Association Between Early Weight Loss and Metabolic Outcomes with Tirzepatide in Japanese Patients with Type 2 Diabetes: A SURPASS J Post Hoc Analysis.

Hanaka Mimura, Tomonori Oura, Rina Chin

|Feb 01, 2025
Association of bodyweight loss with changes in lipids, blood pressure, and fasting serum glucose following tirzepatide treatment in Japanese participants with type 2 diabetes: A post hoc analysis of the SURPASS J-mono trial.

Hanaka Mimura, Tomonori Oura, Rina Chin

|Nov 21, 2024
Investigation of Severe Hypoglycemia Risk Among Patients with Diabetes Treated with Ultra-Rapid Lispro in Japan.

Seiko Mizuno, Machiko Minatoya, Satoshi Osaga

|Nov 11, 2022
Safety and effectiveness of dulaglutide 0.75 mg in Japanese patients with type 2 diabetes in real-world clinical practice: 36 month post-marketing observational study.

Rina Chin, Soshi Nagaoka, Haru Nakasawa

Pageof 1

Frequent Collaborators

2 joint publications

Seiko Mizuno

2 joint publications

Machiko Minatoya

2 joint publications

Satoshi Osaga

2 joint publications

Hanaka Mimura